"Genetic Technologies Limited...is pleased to announce the publication of a research paper in 'The Prostate' validating the utilisation of geneType Prostate Cancer Risk Assessment Test in the identification of men who are at increased risk of this serious disease....The study demonstrated that geneType could enable a more targeted approach to Prostate Specific Antigen (PSA) screening of high-risk men – ultimately providing far greater utility of the PSA screening test."